Trial · NCT07383324
Heat Stress in Individuals With Schizophrenia
NCT07383324, Not applicable, Recruiting, University of Ottawa
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Heat Stress in Individuals With Schizophrenia. Trials, record NCT07383324. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07383324
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Heat Stress in Individuals With Schizophrenia
- NCT number
- NCT07383324
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 10 participants, estimated
- Lead sponsor
- University of Ottawa
- Conditions
- Heat Stress, Physiological Stress, Cognitive Change
- Interventions
- Simulated exposure to indoor overheating
- First posted
- 2026-02-03
- Last updated
- 2026-04-23
Source ClinicalTrials.gov
Registered outcomes29
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Core temperature (Peak) during daylong exposure to indoor overheating | End of 6 hour daylong exposure | Peak core (indexed by visceral temperature) temperature (15 min average) during exposure. Visceral temperature is measured continuously throughout the 6 hour exposure to the simulated indoor overheating. |
| Secondary | Profiles of Mood States (POMS) during daylong exposure to indoor overheating | At the start (hour 0) and end of 6 hour daylong exposure | Potential changes in mood (7 subscales of mood: tension, anger, depression, fatigue, confusion, vigor and esteem related affect). The POMS-40 is a validated, self-administered questionnaire that examines seven distinct aspects of mood state across two positive subscales (Esteem-Related Affect, and Vigor) and five negative subscales (Fatigue, Tension, Confusion, Anger, and Depression), which are described across 40 distinct adjectives. For each individual item, participants are asked to describe "how you feel right now" by responding using a 5-point Likert scale (0 = "Not at all", 1 = "A little", 2 = "Moderately", 3 = "Quite a lot", or 4 = "Extremely"). The values of items associated with a specific subscale (e.g., Fatigue) are summed to calculate its score. |
| Secondary | Environmental Symptoms Questionnaire (ESQ) during daylong exposure to indoor overheating | At the start (hour 0) and end of 6 hour daylong exposure | Self-reported environmental reactions and medical symptomatology associated with prolonged heat exposure. The ESQ-IV is a validated 68-item, self-administered questionnaire that has been used successfully in identifying symptomatology during exposure to a wide variety of environmental conditions, including heat exposure. Participants are asked to assess and described "how you have been feeling today" by responding to each item using a 6-point Likert scale (0 = "Not at all", 1 = "Slight", 2 = "Somewhat", 3 = "Moderate", 4 = "Quite a bit", or 5 = "Extreme"). Total Symptom Score is calculated from this data by taking the sum of the intensity ratings from all 68 individual items using reverse scores for the three positive items from the list ("I Felt Good", "I Felt Alert", and "I Felt Wide Awake"). |
| Secondary | Perceived exertion scale during daylong exposure to indoor temperature limit. | At the start (hour 0) and end of 6 hour daylong exposure | Perceived exertional assessed via an ordinal scale ("How hard are you working?") ranging from "no exertional at all" to "maximal exertion" |
| Secondary | Activity levels (total steps taken) during daylong exposure to indoor overheating | End of 6 hour daylong exposure | Activity levels, quantified by number of steps taken per hour and totaled for each 6 hour exposure, assessed via a wearable accelerometer worn on the wrist and hip. |
| Secondary | Feel good scale during daylong exposure to indoor overheating | At the start (hour 0) and end of 6 hour daylong exposure | Feel good scale assessed via an ordinal scale (How good do you feel?) ranging from "very good" to "very bad" (midpoint: neutral) |
| Secondary | Thirst sensation scale during daylong exposure to indoor overheating | At the start (hour 0) and end of 6 hour daylong exposure | Thirst sensation assessed via an ordinal scale ranging from very, very thirsty to not thirsty at all. |
| Secondary | Thermal comfort scale during daylong exposure to indoor overheating | At the start (hour 0) and end of 6 hour daylong exposure | Thermal comfort assessed via an ordinal scale ("How comfortable does your body temperature feel?") ranging from "very uncomfortable" to "comfortable". |
| Secondary | Thermal sensation 2 scale during daylong exposure to indoor overheating | At the start (hour 0) and end of 6 hour daylong exposure | Thermal sensation assessed via an ordinal scale ("How do you feel?") ranging from "hot" to "cold" (midpoint: neutral) |
| Secondary | Thermal sensation scale during daylong exposure to indoor overheating | At the start (hour 0) and end of 6 hour daylong exposure | Thermal sensation assessed via an ordinal scale (How hot do you feel?) ranging from "extremely hot" to "neutral". |
1 to 10 of 29Source ClinicalTrials.gov
See all 29 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07383324
GET https://conductscience.org/api/trials/v1/NCT07383324/registered?page=2